Software & SaaS

A new study reveals why GLP-1 drugs work for some and not others. 23andMe's research could personalize obesity treatment for millions of patients.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

As AI and automation reshape global tax, a new online certificate from IBFD and VU Amsterdam aims to equip professionals with crucial, future-proof skills.

As online reviews face a crisis of trust, a Bay Area company doubles down on a physical directory, betting that verified quality is worth its weight in paper.

A new report reveals a massive security blind spot. Unmanaged apps, fueled by AI adoption, are causing data breaches, audit failures, and huge financial losses.

A major upgrade to RxERP's platform introduces unit-level audit logging, promising to redefine data integrity and drive efficiency beyond simple compliance.

A new app lets users bet on viral videos, raising over $1M to financialize social media. But does it create a new economy or a new set of risks?

In 2025, a non-profit delivered 53,000 hours of free virtual programs, from pet painting to yoga, creating a new blueprint for aging well.

The energy tech giant completes its EMEA business divestiture to AURELIUS, sharpening focus on the Americas and APAC while reshaping Europe's grid market.

With B2B firms struggling to execute strategy, 2X appoints Emily Atkinson as CCO to operationalize its unified GTM engine and close the widening gap.

The simulation software leader is betting big on its users, launching a high-stakes contest to showcase the future of engineering and boost careers.

The WODMDX 2026 expo returns to Shanghai, leveraging a unique 'precision matching' model to connect global tech with China's industrial giants.

Galloway Capital Partners takes a 5.44% stake in Chegg, arguing the ed-tech firm is undervalued and a strategic split could revive its fortunes.

Jacksonville agency Dion Marketing lands a major account, leveraging AI and SEO to boost local visibility for 39 Monster Mini Golf franchise locations.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

As uranium prices soar, one explorer uses advanced 3D modeling and AI to unlock new discovery potential in Canada's richest uranium district.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

From commercial fleets to combat readiness, Xos targets the defense sector with its grid-independent mobile charging platform for military operations.

With Arizona's 2026 elections heating up, Clean Elections reveals its lineup of veteran journalists to moderate the debates. Here's what's at stake.

CorTec's brain-computer interface gets FDA Breakthrough status, offering new hope for restoring movement in millions of chronic stroke survivors.